Interruption of Dorsal Visual Stream Using TMS - Full Text View

Interruption of Dorsal Visual Stream Using TMS

This study is currently recruiting participants.
Verified by Sheba Medical Center, January 2007

Sponsored by:	Sheba Medical Center
Information provided by:	Sheba Medical Center
ClinicalTrials.gov Identifier:	NCT00418652

Purpose

Trans Cranial Magnetic Stimulation (TMS) over dorsal visual system will disturb the ability to identify objects with decreased level of fragmentation

Condition	Intervention
Healthy	Device: Transcranial Magnetic Stimulation

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Diagnostic, Randomized, Single Blind, Placebo Control, Parallel Assignment

Official Title:	Interruption of Dorsal Visual Stream Using TMS in Normal Controls

Further study details as provided by Sheba Medical Center:

Estimated Enrollment:	12
Study Start Date:	October 2006

Eligibility

Criteria

Inclusion Criteria:

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00418652

Contacts


Contact: Revital Amiaz, MD	972-52-6666571	revital.amiaz@sheba.health.gov.il

Locations


Israel
	Psychiatry Clinic - Sheba Medical Center	Recruiting
	TEL-HASHOMER, Israel, 52621
	Contact: Revital Amiaz, MD 972-52-6666571 revital.amiaz@sheba.health.gov.il

Sponsors and Collaborators

Sheba Medical Center

Investigators


Principal Investigator:	Revital Amiaz, MD	Sheba Medical Center

More Information

Study ID Numbers:	SHEBA-06-4252-RA-CTIL
First Received:	January 4, 2007
Last Updated:	January 4, 2007
ClinicalTrials.gov Identifier:	NCT00418652
Health Authority:	Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Sheba Medical Center:

Normal Controls

Study placed in the following topic categories:

Healthy

ClinicalTrials.gov processed this record on December 10, 2008